Glycostem is a clinical stage biotech company developing off-the shelf allogeneic cellular immunotherapy using Natural Killer (NK) cells.

Biotechnology

Glycostem Therapeutics

Glycostem Therapeutics' headquarters in Oss, Netherlands

This department ensures that products meet specific quality standards and regulatory requirements through rigorous testing and inspection processes.

This department focuses on identifying and creating growth opportunities through strategic partnerships and product innovation.

This department guides the overall strategic direction and management of the organization.

This department manages employee relations, recruitment, training, and organizational development.

This department focuses on conducting scientific research and analysis to advance knowledge and innovation.